StockData
InflaRx N.V. logo

InflaRx N.V. (IFRX) stock

IFRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 5/30
$1.18+0.01 (+0.85%)

Close on Nov 16, 2026Market cap $85.31MP/E –Yield –

InflaRx total assets

Total assets on the balance sheet at the end of each period.

InflaRx's total assets was €55.22M at Dec 31, 2025. For fiscal 2025 it was €55.22M, down 27.4% from the year before. The highest annual figure on record is €159.21M in fiscal 2018.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025€55.22M-27.4%
FY2024Dec 31, 2024€76.02M-36.8%
FY2023Dec 31, 2023€120.21M+17.4%
FY2022Dec 31, 2022€102.40M-18.2%
FY2021Dec 31, 2021€125.14M+41.9%
FY2020Dec 31, 2020€88.22M-27.4%
FY2019Dec 31, 2019€121.58M-23.6%
FY2018Dec 31, 2018€159.21M+28.2%
FY2017Dec 31, 2017€124.21M+320.8%
FY2016Dec 31, 2016€29.52M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025€55.22M-54.1%
Q2 FY2025Jun 30, 2025€73.44M-44.8%
Q4 FY2024Dec 31, 2024€76.02M-25.8%
Q2 FY2024Jun 30, 2024€93.04M-18.8%
Q4 FY2023Dec 31, 2023€120.21M-3.9%
Q2 FY2023Jun 30, 2023€132.96M+50.7%
Q4 FY2022Dec 31, 2022€102.40M-15.8%
Q2 FY2022Jun 30, 2022€114.63M-20.9%
Q4 FY2021Dec 31, 2021€125.14M-21.4%
Q4 FY2020Dec 31, 2020€88.22M-29.0%
Q4 FY2019Dec 31, 2019€121.58M+311.9%
Q2 FY2019Jun 30, 2019€144.92M–
Q4 FY2018Dec 31, 2018€159.21M–
Q4 FY2017Dec 31, 2017€124.21M–
Q4 FY2016Dec 31, 2016€29.52M–

More InflaRx figures

See a number that looks wrong?